T1	Participants 108 227	patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study
T2	Participants 288 488	prophylactic effects of capsule forms of fluconazole (n = 110) and itraconazole (n = 108) in patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) during and after chemotherapy
T3	Participants 1301 1351	patients with AML or MDS who received chemotherapy
